Drug Myths, Trends and Opportunities to Intervene

Monday, May 1, 2023, 12:00 AM - Friday, May 1, 2026, 12:00 AM

This module is available for Corewell Health East (Beaumont) Providers and Employees only.

This module provides an overview of current commonly used illicit drugs, discusses common misconceptions surrounding fentanyl, and describes current medication assisted treatment options for people who use drugs.

Release Date: May 1, 2023 | Expiration Date: May 1, 2026 | Estimated Time to Complete: 1 hour

Module provided by the Corewell Health West Dependent Drug Stewardship Program

1. Describe common drugs in our community/country
2. Describe new and emerging substances being introduced into the illicit drug market
3. Review current drug poisoning trends both nationally and locally
4. Review common myths and misconceptions about substances
5. Describe substance use treatment and opportunities to provide harm reductive care in clinical practice

This module is available to Corewell Health East providers only. 

To access the module, you must log into the CME portal using the "Sign in with your Beaumont Health ID" option.

This module meets the DEA MATE Act requirements.

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Non-Physician (Attendance) (1.00 hours), Pain and Symptom Management (1.00 hours), APA Psychology CE (1.00 hours), Nursing CE (ANCC) (1.00 hours), Pharmacist CE (ACPE) (1.00 hours), Social Work CE (ASWB) (1.00 hours), Pharmacy Technician CE (ACPE) (1.00 hours)

In support of improving patient care, Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Medicine CME: Beaumont Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing CE: Beaumont Health designates this activity for a maximum of 1.0 ANCC contact hour.  Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy CE: Beaumont Health designates this activity for 1.0 ACPE contact hour. ACPE Universal Activity Number (UAN): JA4008259-0000-23-096-H08-P; JA4008259-0000-23-096-H08-T.  Learners should claim only the credit commensurate with the extent of their participation in the activity.  Credit will be uploaded to the NABP CPE Monitor within 30 days after activity completion.  Per ACPE rules, Beaumont Health does not have access nor the ability to upload credits requested after 60 days.  It is the individual learner’s responsibility to provide the correct NABP ID and DOB (MMDD) to receive credit.

Psychology CE: Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. 

 

Social Work CE:  As a Jointly Accredited Organization, Beaumont Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 continuing education credit.

State of Michigan LARA: This module provides 1 hour of pain and symptom management credit.

Drug Enforcement Administration: This module provides 1 hour of training for Medication Assisted Treatment as part of the DEA MATE Act.

Mitigation of Relevant Financial Relationships

Beaumont Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.